[Activated phosphoinositide 3-kinase delta syndrome: report of seven cases]

Qing-Hua Liu1, Li Peng1, Han Huang1

  • 1Pediatric Medical Center, First Hospital Affiliated to Hunan Normal University/Hunan Provincial People's Hospital/Hunan Provincial Key Laboratory of Pediatric Respiratory Disease, Changsha 410005, China.

Insights

Activated phosphoinositide 3-kinase delta syndrome (APDS) in children often presents with recurrent infections and enlarged lymph nodes. Early recognition of key symptoms is crucial for timely diagnosis and management of this rare immune disorder.

Area of Science:

  • Immunology
  • Genetics
  • Pediatrics

Background:

  • Activated phosphoinositide 3-kinase delta syndrome (APDS) is a primary immunodeficiency.
  • Understanding the clinical spectrum and genetic basis of APDS is essential for diagnosis.

Purpose of the Study:

  • To summarize clinical data of 7 children diagnosed with APDS.
  • To enhance the understanding of APDS in pediatric patients.

Main Methods:

  • Retrospective analysis of clinical data from 7 APDS children.
  • Data collected from January 2019 to August 2023 at Hunan Provincial People's Hospital.

Main Results:

  • All 7 children experienced recurrent respiratory infections, hepatosplenomegaly, and lymphadenopathy.
  • Common findings included sepsis (5/7), otitis media (3/7), and caries (3/7).
  • The p.E1021K mutation was identified in 6 patients, and a splice site mutation in one.

Conclusions:

  • The p.E1021K mutation is the most frequent genetic alteration in pediatric APDS.
  • Suspicion of APDS is warranted in children with recurrent infections, hepatosplenomegaly, lymphadenopathy, otitis media, or caries, especially with bronchoscopic findings of nodular protrusions.
Abstract

Related Concept Videos

Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and produces two-second...